# CADARET, GRANT & CO., INC. X-17A-5 (2022-03-30) — Broker-dealer annual report

- Company: CADARET, GRANT & CO., INC.
- Form: X-17A-5
- Filed: 2022-03-30
- Period: 2021-12-31
- Accession: 0000702948-22-000002
- CIK: 702948
- File #: 8-27844
- Type: Broker-dealer
- Material weakness: No
- Auditor: Citrin Cooperman, LLP
- Auditor location: New York, NY
- Contact: Donald J. Taylor
- Phone: 3154712191
- Email: dtaylor@cadaretgrant.com
- Website: cadaretgrant.com
- Signed by: Donald J. Taylor (Managing Director, CFO)

Original filing: https://www.sec.gov/Archives/edgar/data/702948/000070294822000002/CGshortreport21.pdf

---

{0}------------------------------------------------

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

OMB APPROVAL OMB Number: 3235-0123 Expires: Oct. 31, 2023 Estimated average burden hours per response:

# ANNUAL REPORTS FORM X-17A-5 PART III

SEC FILE NUMBER 8-27844

FACING PAGE

Information Required Pursuant to Rules 17a-5, 17a-12, and 18a-7 under the Securities Exchange Act of 1934

| FILING FOR THE PERIOD BEGINNING                                                                                                                                                                                        | 01/01/2021                                                         | AND ENDING | 12/31/2021                                 |  |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------|------------|--------------------------------------------|--|
| P                                                                                                                                                                                                                      | MM/DD/YY                                                           |            | MM/DD/YY                                   |  |
|                                                                                                                                                                                                                        | A. REGISTRANT IDENTIFICATION.                                      |            |                                            |  |
| Cadaret Grant &Co., hc.<br>NAME OF FIRM:                                                                                                                                                                               |                                                                    |            |                                            |  |
| TYPE OF REGISTRANT (check all applicable boxes):<br>M Broker-dealer<br>Check here if respondent is also an OTC derivatives dealer                                                                                      | Security-based swap dealer   Major security-based swap participant |            |                                            |  |
| ADDRESS OF PRINCIPAL PLACE OF BUSINESS: (Do not use a P.O. box no.)                                                                                                                                                    |                                                                    |            |                                            |  |
| 100 Madison St., Suite 1300                                                                                                                                                                                            |                                                                    |            |                                            |  |
|                                                                                                                                                                                                                        | (No. and Street)                                                   |            |                                            |  |
| Syracuse                                                                                                                                                                                                               | NY                                                                 |            | 13039                                      |  |
| (City)                                                                                                                                                                                                                 | (State)                                                            |            | (Zip Code)                                 |  |
| PERSON TO CONTACT WITH REGARD TO THIS FILING                                                                                                                                                                           |                                                                    |            |                                            |  |
| Donald J. Taylor                                                                                                                                                                                                       | (315) 471-2191                                                     |            | dtaylor@cadaretgrant.com                   |  |
| (Name)                                                                                                                                                                                                                 | (Area Code - Telephone Number)                                     |            | (Email Address)                            |  |
|                                                                                                                                                                                                                        | B. ACCOUNTANT IDENTIFICATION                                       |            |                                            |  |
| INDEPENDENT PUBLIC ACCOUNTANT whose reports are contained in this filing*                                                                                                                                              |                                                                    |            |                                            |  |
| Citrin Cooperman, LLP                                                                                                                                                                                                  |                                                                    |            |                                            |  |
|                                                                                                                                                                                                                        | (Name - if individual, state last, first, and middle name)         |            |                                            |  |
| 50 Rockefeller Plaza                                                                                                                                                                                                   | New York                                                           | NY         | 10020                                      |  |
| (Address)                                                                                                                                                                                                              | (City)                                                             | (State)    | (Zip Code)                                 |  |
| 11/02/2005                                                                                                                                                                                                             |                                                                    | 2468       |                                            |  |
| (Date of Registration with PCAOB)(if applicable)                                                                                                                                                                       |                                                                    |            | (PCAOB Registration Number, if applicable) |  |
|                                                                                                                                                                                                                        | FOR OFFICIAL USE ONLY                                              |            |                                            |  |
| * Claims for exemption from the requirement that the annual reports of an independent public<br>accountant must be supported by a statement of facts and circumstances relied on as the basis of the exemption. See 17 |                                                                    |            |                                            |  |

CFR 240.17a-5(e)(1)(ii), if applicable.

Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

{1}------------------------------------------------

#### OATH OR AFFIRMATION

| Donald J. Taylor                                                                   | swear (or affirm) that, to the best of my knowledge and belief, the                                                     |
|------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|
| financial report pertaining to the firm of                                         | Cadaret, Grant & Co., Inc.<br>, as of                                                                                   |
| December 31                                                                        | 2 021_ is true and correct. I further swear (or affirm) that neither the company nor any                                |
|                                                                                    | partner, officer, director, or equivalent person, as the case may proprietary interest in any account classified solely |
| as that of a customer.                                                             |                                                                                                                         |
| SARA A KERRY                                                                       |                                                                                                                         |
| NOTARY PUBLIC-STATE OF NEW YORK<br>No. 01KE6232868<br>Qualified In Onondaga County | Signature:<br>Title:                                                                                                    |
| My Commission Expires December 13, 2Q2JJ                                           | Managing Director, CFO                                                                                                  |
| Notary Public                                                                      |                                                                                                                         |

#### This filing\*\* contains (check all applicable boxes):

- (a) Statement of financial condition.
- (b) Notes to consolidated statement of financial condition.
- | (c) Statement of income (loss) or, if there is other comprehensive income in the period(s) presented, a statement of comprehensive income (as defined in § 210.1-02 of Regulation S-X).
- [d) Statement of cash flows.
- [ (e) Statement of changes in stockholders' or partners' or sole proprietor's equity.
- [f) Statement of changes in liabilities subordinated to claims of creditors.
- [g) Notes to consolidated financial statements.
- [ (h) Computation of net capital under 17 CFR 240.15c3-1 or 17 CFR 240.18a-1, as applicable.
- [ (i) Computation of tangible net worth under 17 CFR 240.18a-2.
- [ [] Computation for determination of customer reserve requirements pursuant to Exhibit A to 17 CFR 240.15c3-3.
- | (k) Computation for determination of security-based swap reserve requirements pursuant to Exhibit B to 17 CFR 240.15c3-3 or Exhibit A to 17 CFR 240.18a-4, as applicable.
- [1) Computation for Determination of PAB Requirements under Exhibit A to § 240.15c3-3.
- [m] Information relating to possession or control requirements for customers under 17 CFR 240.15c3-3.
- | (n) Information relating to possession or control requirements for security-based swap customers under 17 CFR 240.15c3-3(p)(2) or 17 CFR 240.18a-4, as applicable.
- | (o) Reconciliations, including appropriate explanations, of the FOCUS Report with computation of net capible net worth under 17 CFR 240.15c3-1, 17 CFR 240.18a-1, or 17 CFR 240.18a-2, as applicable, and the reserve requirements under 17 CFR 240.15c3-3 or 17 CFR 240.18a-4, as applicable, if material differences exist, or a statement that no material differences exist.
- [p) Summary of financial data for subsidiaries not consolidated in the statement of financial condition.
- (q) Oath or affirmation in accordance with 17 CFR 240.17a-5, 17 CFR 240.17a-12, or 17 CFR 240.18a-7, as applicable.
- [r) Compliance report in accordance with 17 CFR 240.17a-5 or 17 CFR 240.18a-7, as applicable.
- [s) Exemption report in accordance with 17 CFR 240.17a-5 or 17 CFR 240.18a-7, as applicable.
- [t) Independent public accountant's report based on an examination of the statement of financial condition.
- [u] Independent public accountant's report based on an examination of the financial statements under 17 CFR 240.17a-5, 17 CFR 240.18a-7, or 17 CFR 240.17a-12, as applicable.
- [ (v) Independent public accountant's report based on an examination of certain statements in the compliance report under 17 CFR 240.17a-5 or 17 CFR 240.18a-7, as applicable.
- [w] Independent public accountant's report based on a review of the exemption report under 17 CFR 240.17a-5 or 17 CFR 240.18a-7, as applicable.
- | (x) Supplemental reports on applying agreed-upon procedures, in accordance with 17 CFR 240.17a-12, as applicable.
- | (y) Report describing any material inadequacies found to have existed since the date of the previous audit, or a statement that no material inadequacies exist, under 17 CFR 240.17a-12(k).
- [ (z) Other:
- \*\* To request confidential treatment of certain portions of this filing, see 17 CFR 240.170-5(e)(3) or 17 CFR 240.180-7(d)(2), as applicable.

{2}------------------------------------------------

{3}------------------------------------------------

#### **CADARET, GRANT & CO., INC. DECEMBER 31, 2021**

### **TABLE OF CONTENTS**

|                                                         | Page  |
|---------------------------------------------------------|-------|
| REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | 1     |
| FINANCIAL STATEMENT                                     |       |
| Statement of Financial Condition                        | 2     |
| Notes to Statement of Financial Condition               | 3 - 9 |

{4}------------------------------------------------

![](_page_4_Picture_0.jpeg)

# **REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

To the Stockholder and the Board of Directors Cadaret, Grant & Co., Inc.

### **Opinion on the Financial Statement**

We have audited the accompanying statement of financial condition of Cadaret, Grant & Co., Inc. as of December 31, 2021, and the related notes (collectively referred to as the "financial statement"). In our opinion, the financial statement presents fairly, in all material respects, the financial position of Cadaret, Grant & Co., Inc. as of December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.

### **Basis for Opinion**

This financial statement is the responsibility of Cadaret, Grant & Co., Inc.'s management. Our responsibility is to express an opinion on Cadaret, Grant & Co., Inc.'s financial statement based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to Cadaret, Grant & Co., Inc. in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statement is free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statement, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statement. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statement. We believe that our audit provides a reasonable basis for our opinion.

We have served as Cadaret, Grant & Co., Inc.'s auditor since 2011. New York, New York March 29, 2022

{5}------------------------------------------------

| ASSETS                       |                  |  |
|------------------------------|------------------|--|
|                              |                  |  |
| Cash and cash equivalents    | \$<br>14,307,826 |  |
| Commissions receivable       | 6,580,000        |  |
| Deposit with clearing broker | 250,000          |  |
| Other receivables            | 2,102,626        |  |
| Other assets                 | 1,427,936        |  |
| Right-of-use assets          | 5,458,990        |  |
| Fixed assets, net            | 1,311,160        |  |
| Deferred tax assets          | 11,412,215       |  |
| TOTAL ASSETS                 | \$ 42,850,753    |  |

#### **LIABILITIES AND STOCKHOLDER'S EQUITY**

| Liabilities:                                                                                                                               |                                           |
|--------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------|
| Accounts payable and accrued expenses<br>Lease liability<br>Commissions payable                                                            | \$<br>5,219,144<br>4,411,085<br>5,938,384 |
| Total liabilities                                                                                                                          | 15,568,613                                |
| Stockholder's equity:                                                                                                                      |                                           |
| Common stock, \$0.01 par value; 400,000 shares<br>104,688 shares issued and outstanding<br>Additional paid-in capital<br>Retained earnings | 1,047<br>135,239<br>27,145,854            |
| Total stockholder's equity                                                                                                                 | 27,282,140                                |
| TOTAL LIABILITIES AND STOCKHOLDER'S EQUITY                                                                                                 | \$ 42,850,753                             |

See accompanying notes to financial statements.

{6}------------------------------------------------

#### **NOTE 1. ORGANIZATION AND NATURE OF BUSINESS**

Cadaret, Grant & Co., Inc. (the "Company") is a registered broker-dealer with the Securities and Exchange Commission ("SEC") and is a member of the Financial Industry Regulatory Authority, Inc. ("FINRA"). The Company is a wholly-owned subsidiary of a financial services company (the "Parent"). The Company's principal office is located in Syracuse, New York. The Company has registered representatives located throughout the United States. Major sources of revenues are investment advisory fees and commissions from sales of mutual funds and insurance products. Other sources of revenues are commissions from sales of corporate stocks, municipal bonds and other securities.

#### **NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

#### Cash and cash equivalents

Cash equivalents consist of highly liquid investments with original maturities of less than 90 days that are not held for sale in the ordinary course of business.

#### Basis of presentation and use of estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("US GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

### Securities transactions

Proprietary securities transactions are recorded on the trade date, as if they had settled. Profit and loss arising from all securities transactions entered into for the account and risk of the Company are recorded on a trade date basis. Customers' securities transactions are reported on a settlement date basis, with related commission income and expense reported on a trade date basis.

#### Commissions and other receivables

Commissions and other receivables are stated at the amounts the Company expects to collect. The Company considers accounts receivable to be fully collectible. The determination of the amount of credit losses is based on the estimated creditworthiness of the counterparty and the length of time a receivable has been outstanding. Other factors are considered by management based on relevant information about past events, current conditions and reasonable supportable forecasts as deemed necessary on a transaction-by-transaction basis. The Company continually monitors these estimates over the life of the receivable. The allowance for uncollectible accounts reflects the amount of loss that can be reasonably estimated by management. No allowance for credit losses was recorded as of December 31, 2021. The total of Commissions and other receivables at December 31, 2020 and December 31, 2021 was \$9,283,919 and \$8,682,626, respectively.

#### Fixed assets

Fixed assets are stated at cost and are depreciated based on their estimated useful lives using accelerated methods. Useful lives range from 3 to 7 years.

{7}------------------------------------------------

### **NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)**

#### Right-of-use assets and lease liabilities

The Company recognizes its leases in accordance with ASC Topic 842, *Leases* ("ASC 842"). The guidance increases transparency and comparability by requiring the recognition of right-of-use ("ROU") assets and lease liabilities on the statement of financial condition.

The Company conducts an analysis of contracts, including real estate leases and service contracts to identify embedded leases, to determine the initial recognition of ROU assets and lease liabilities, which required subjective assessment over the determination of the associated discount rates.

The discount rate is the implicit rate if it is readily determinable or otherwise the Company uses its incremental borrowing rate. The implicit rates of the Company's leases are not readily determinable and accordingly, the Company uses its incremental borrowing rate based on the information available at the commencement date for all leases. The Company's incremental borrowing rate for a lease is the rate of interest it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms and in a similar economic environment. The present value of the lease payments was determined using a 3.45% incremental borrowing rate.

The Company has elected, for all underlying classes of assets, to not recognize ROU assets and lease liabilities for short-term leases that have a lease term of 12 months or less at lease commencement, and do not include an option to purchase the underlying asset that the Company is reasonably certain to exercise. The Company recognizes lease costs associated with short-term leases on a straight-line basis over the lease term.

The Company's office space leases require it to make variable payments for the Company's proportionate share of the building's property taxes, insurance, and common area maintenance. These variable lease payments are not included in lease payments used to determine lease liability and are recognized as variable costs when incurred. The term of the office space lease is 11 years.

#### Income taxes

The Company accounts for income taxes under the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the difference are expected to affect taxable income. Valuation allowances are established when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized.

The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgement occurs.

{8}------------------------------------------------

#### **NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)**

#### Fair value measurements

Pursuant to FASB ASC 820, *Fair Value Measurement*, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market. Valuation techniques that are consistent with the market, income or cost approach, as specified by FASB ASC 820, are used to measure fair value.

Using the provisions within FASB ASC 820, the Company has characterized its investments in securities, based on the order of liquidity of the inputs used to value the investments, into a three-level fair value hierarchy. The fair value hierarchy gives the highest order of liquidity to quoted prices in active markets for identical assets or liabilities [Level 1], and the lowest order of liquidity to unobservable inputs [Level 3]. If the inputs used to measure the investments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the investment.

The three levels of the fair value hierarchy under FASB ASC 820 are described as follows:

Level 1 inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.

Level 2 inputs to the valuation methodology include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in inactive markets; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.

{9}------------------------------------------------

#### **NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)**

#### Current expected credit losses

ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326) introduced a credit loss methodology, Current Expected Credit Losses (CECL), which requires earlier recognition of credit losses, while also providing additional transparency about credit risk.

The CECL methodology utilizes a lifetime "expected credit loss" measurement objective for the recognition of credit losses for loans, held-to-maturity securities and other receivables at the time the financial asset is originated or acquired. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. The methodology replaced the multiple existing impairment methods in current GAAP, which generally required that a loss be incurred before it is recognized.

For financial assets measured at amortized cost (e.g. cash and cash equivalents and receivables from clients), the Company has concluded that there are de minimus expected credit losses based on the nature and contractual life or expected life of the financial assets and immaterial historic and expected losses.

#### Subsequent events

The Company evaluates events occurring after the date of the statement of financial condition for potential recognition or disclosure in its financial statements. The Company evaluated subsequent events through March 29, 2022, which is the date the financial statements were issued. The Company did not identify any material subsequent events requiring adjustment to or disclosure in its financial statements.

#### **NOTE 3. CONCENTRATIONS OF CREDIT RISK**

The Company is engaged in various trading and brokerage activities in which counterparties primarily include broker-dealers and other financial institutions. In the event counterparties do not fulfill their obligations, the Company may be exposed to risk. The risk of default depends on the creditworthiness of the counterparty or issuer of the instrument. It is the Company's policy to review, as necessary, the credit standing of each counterparty.

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash accounts in financial institutions that periodically exceed federally insured limits. At December 31, 2021, the amount in cash accounts exceeding federally insured limits was approximately \$2,303,000.

#### **NOTE 4. DEPOSIT WITH CLEARING BROKER**

The Company clears certain of its proprietary and customer transactions through another broker-dealer on a fully-disclosed basis. The clearing agreement requires the Company to maintain a deposit of \$250,000 with the clearing broker. Such amount bears interest at current market rates.

{10}------------------------------------------------

#### **NOTE 5. FAIR VALUE MEASUREMENTS**

Assets and liabilities measured at fair value are based on one or more of three valuation techniques. The valuation techniques are as follows:

- (a) *Market approach*. Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities;
- (b) *Cost approach*. Amount that would be required to replace the service capacity of an asset (replacement cost); and
- (c) *Income approach*. Techniques to convert future amounts to a single present amount based on market expectations (including present value techniques, option-pricing and excess earnings models).

The following table presents the Company's fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis as of December 31, 2021:

| Assets:                                                      | Level 1      | Level 2 | Level 3 | Total        | Valuation<br>technique |
|--------------------------------------------------------------|--------------|---------|---------|--------------|------------------------|
| Money market funds, included in cash<br>and cash equivalents | \$11,751,553 | \$0     | \$0     | \$11,751,553 | (a)                    |

There were no transfers between levels during the year.

### **NOTE 6. INCOME TAXES**

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities as of December 31, 2021 are as follows:

Noncurrent deferred tax assets:

| Intangibles                          | \$<br>11,525,207 |
|--------------------------------------|------------------|
| Other assets                         | 187,822          |
| Lease liability                      | 1,132,534        |
| Total deferred tax assets            | 12,845,563       |
| Noncurrent deferred tax liabilities: |                  |
| Fixed assets                         | (336,637)        |
| Right-of-use asset                   | (991,797)        |
| Lessor incentives                    | (104,914)        |
| Total deferred tax liabilities       | (1,433,348)      |
| Total deferred tax assets, net       | \$<br>11,412,215 |

{11}------------------------------------------------

### **NOTE 6. INCOME TAXES (CONTINUED)**

The Company recognizes valuation allowances on deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized. The Company has concluded that it is currently more likely than not that the net deferred tax assets will be realized and has not established a valuation allowance at December 31, 2021. In the event the Company is charged interest or penalties related to income tax matters, the Company would record such interest as income tax expense and would record such penalties as other expenses in the separately stated financial statements. No such charges have been incurred by the Company for 2021. For the year ended December 31, 2021, the Company had no uncertain tax positions.

### **NOTE 7. FIXED ASSETS**

Fixed assets consisted of the following at December 31, 2021:

| Furniture and fixtures         | \$<br>120,192   |
|--------------------------------|-----------------|
| Leasehold improvements         | 1,158,120       |
| Equipment                      | 3,677,475       |
|                                | 4,955,787       |
| Less: accumulated depreciation | (3,644,627)     |
| Fixed assets, net              | \$<br>1,311,160 |

### **NOTE 8. COMMITMENTS AND CONTINGENCIES**

In the normal course of business, the Company may be a party to litigation or other regulatory matters. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, the estimated liability would be accrued in the Company's financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss, if determinable and material, would be disclosed.

#### **NOTE 9. RELATED-PARTY TRANSACTIONS**

Pursuant to an administrative service arrangement ("Affiliate Arrangement") with affiliated organizations, the Company is reimbursed and pays for services provided by certain employees and for overhead expenses it pays for these entities. At December 31, 2021, there is a receivable of \$1,744 from the affiliates included in other receivables and a payable of \$41,108 to the affiliates included in accounts payable and accrued expenses in the accompanying statement of financial condition.

Pursuant to an administrative service arrangement ("Parent Arrangement") with the Parent, the Company is reimbursed and pays for services provided by certain employees and for overhead expenses of the Company that are paid by the Parent. At December 31, 2021, there is a payable of \$319,283 to the Parent that is included in accounts payable and accrued expenses in the accompanying statement of financial condition.

{12}------------------------------------------------

### **NOTE 10. NET CAPITAL REQUIREMENT**

As a registered broker-dealer, the Company is subject to the SEC's Uniform Net Capital Rule ("SEC Rule15c3-1"), which requires the Company to maintain minimum net capital, as defined. Further, the rule requires that the ratio of aggregate indebtedness, as defined, to net capital shall not exceed 15 to 1.

At December 31, 2021, the Company had net capital of \$8,299,449, which was \$7,527,032 in excess of its required net capital of \$772,417. The Company's percentage of aggregate indebtedness to net capital was 140% at December 31, 2021.

### **NOTE 11. PROFIT SHARING PLAN**

The Company has a qualified profit-sharing retirement plan ("Plan") with a 401(k) deferred compensation provision covering all eligible employees as described in the Plan. The Company may make matching and/or discretionary contributions to the Plan, which are determined annually by management.


Source: SEC EDGAR via Adviser Search (https://search.stillhousedata.com). Agents: see https://search.stillhousedata.com/llms.txt.
